Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kata L Chillag, PhD
Centers for Disease Control and Prevention
Principal Investigator - Kenneth H. Mayer, MD
Fenway Community Health
Principal Investigator - Lisa A Grohskopf, MD, MPH
Centers for Disease Control and Prevention
Principal Investigator - Melanie Thompson, MD
AIDS Research Consortium of Atlanta
Principal Investigator - Susan Buchbinder, MD
San Francisco Dept. of Public Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Francisco Department of Public Health
San Francisco, California, United States
- Aids Research Consortium of Atlanta
Atlanta, Georgia, United States
- Fenway Community Health
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2005
- Primary completion
- 31 Aug 2009
- Completion
- 31 Aug 2009
- Last update posted
- 10 Mar 2014
- Registered enrollment
- 400
- Registry id
- NCT00131677
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.